Showing results (1-10 of 63) with videos related to
Sort By:
Pageof 7
Therapeutic Drug Monitoring|September 11, 2012
Safe and effective variability-a criterion for dose individualizationNicholas H G Holford, Thierry BuclinPaediatric Anaesthesia|February 16, 2011
Tips and traps analyzing pediatric PK dataBrian J Anderson, Nick H G HolfordArchives of Disease in Childhood|July 9, 2013
Understanding dosing: children are small adults, neonates are immature childrenBrian J Anderson, Nick H G HolfordMovement Disorders : Official Journal of the Movement Disorder Society|October 3, 2002
Quantitative description of loss of clinical benefit following withdrawal of levodopa-carbidopa and bromocriptine in early Parkinson's diseaseRobert A Hauser, Nicholas H G HolfordAnnual Review of Pharmacology and Toxicology|October 5, 2007
Mechanism-based concepts of size and maturity in pharmacokineticsB J Anderson, N H G HolfordPaediatric Anaesthesia|February 16, 2011
Predicting weight using postmenstrual age--neonates to adultsAnita L Sumpter, Nick H G HolfordMovement Disorders : Official Journal of the Movement Disorder Society|March 4, 2011
Interpreting the results of Parkinson's disease clinical trials: time for a changeNick H G Holford, John G NuttBritish Journal of Clinical Pharmacology|February 4, 2017
Why standards are useful for predicting dosesNick H G Holford, Brian J AndersonPaediatric Anaesthesia|October 11, 2018
Negligible impact of birth on renal function and drug metabolismBrian J Anderson, Nick H G HolfordDrug Metabolism and Pharmacokinetics|March 3, 2009
Mechanistic basis of using body size and maturation to predict clearance in humansBrian J Anderson, Nick H G HolfordPageof 7